...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Prescription pattern in cases of ischemic stroke in general medicine department in Government General Hospital, Kakinada, Andhra Pradesh
【24h】

Prescription pattern in cases of ischemic stroke in general medicine department in Government General Hospital, Kakinada, Andhra Pradesh

机译:政府综合医院普通医学署缺血性脑卒中病例的处方模式,Kakinada,Andhra Pradesh

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Stroke, as a one of the leading causes of mortality and disability, is also very preventable and curable disease. Pharmacotherapy plays an important role in prevention of first-ever stroke as well as secondary cerebrovascular accident. We aimed to evaluate the prescription pattern in cases of ischemic stroke and to check whether rationale prescription of drugs in ischemic stroke patients is being followed in our hospital.Methods: A prospective observational study was conducted in inpatient department of general medicine in government general hospital, Kakinada for a period of six months from April to September 2018. A total of 306 prescriptions of ischemic stroke were selected randomly and prescriptions patterns were assessed and analyzed.Results: Out of the 306 cases, 183 were males (59.80%) and 123 were female (40.19%). Aspirin was given in 88.23% of the patients, Atorvastatin in 97.05%, Clopidogrel in 24.50%, antihypertensives in 67.64%, B complex in 88.23%, Pantoprazole in 85.29% of the patients. Physiotherapy was advised in 47.05% of the patients. Among anti hypertensives, Amlodipine was given in 73.91% patients.Conclusions: Anti hypertensives, lipid lowering agents like Atorvastatin along with anti-platelet drugs like Aspirin and Clopidogrel were commonly prescribed for ischemic stroke cases for treatment and secondary prevention. Antacids and Multivitamin tablets were given as concomitant drugs. Present study showed a rationale utilization of drugs in ischemic stroke patients.
机译:背景:中风,作为死亡率和残疾的主要原因之一,也是非常可预防和可治愈的疾病。药物疗法在预防首次中风以及中脑血管事故中起着重要作用。我们旨在评估缺血性卒中病例中的处方模式,并检查我们的医院是否正在遵循缺血性脑卒中患者药物的理由处方。方法:在政府综合医院的一般医学部门进行了一个前瞻性观察研究, kakinada从4月到2018年4月的六个月。随机选择了306例缺血性卒中处方,并评估并分析了处方模式。结果:从306例中,183例为男性(59.80%)和123例女性(40.19%)。阿司匹林在88.23%的患者中,阿托伐他汀在97.05%,氯吡格雷均为24.50%,抗高血压症在67.64%,B络合物中88.23%,泮托拉唑在85.29%的患者中。在47.05%的患者中建议了物理疗法。在抗高血压症中,氨氯地平在73.91%的患者中给出。结论:抗高血压剂,脂质降低剂,如阿司凡汀和抗血小板药物,如阿司匹林和氯吡格雷,用于治疗和二次预防的缺血性卒中病例。作为伴随药物给予抗酸剂和多种维生素片剂。目前的研究表明,缺血性卒中患者药物的理由利用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号